Cochrane Abstracts
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Versus Urinary Gonadotrophin for Ovarian Stimulation in Assisted Reproductive Technology Cycles." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438319/all/Recombinant_versus_urinary_gonadotrophin_for_ovarian_stimulation_in_assisted_reproductive_technology_cycles. Accessed 09 September 2024.
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438319/all/Recombinant_versus_urinary_gonadotrophin_for_ovarian_stimulation_in_assisted_reproductive_technology_cycles. Accessed September 9, 2024.
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438319/all/Recombinant_versus_urinary_gonadotrophin_for_ovarian_stimulation_in_assisted_reproductive_technology_cycles
Recombinant Versus Urinary Gonadotrophin for Ovarian Stimulation in Assisted Reproductive Technology Cycles [Internet]. In: Cochrane Abstracts. [cited 2024 September 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438319/all/Recombinant_versus_urinary_gonadotrophin_for_ovarian_stimulation_in_assisted_reproductive_technology_cycles.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles
ID - 438319
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438319/all/Recombinant_versus_urinary_gonadotrophin_for_ovarian_stimulation_in_assisted_reproductive_technology_cycles
DB - Evidence Central
DP - Unbound Medicine
ER -
